GlucoTrack, Inc.
GCTK
$0.1714
-$0.0026-1.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.16M | 1.19M | 902.00K | 803.00K | 675.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.85M | 3.25M | 4.49M | 2.95M | 2.42M |
| Operating Income | -3.85M | -3.25M | -4.49M | -2.95M | -2.42M |
| Income Before Tax | -10.09M | -5.09M | -4.49M | -2.93M | -2.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.09M | -5.09M | -4.49M | -2.93M | -2.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.09M | -5.09M | -4.49M | -2.93M | -2.41M |
| EBIT | -3.85M | -3.25M | -4.49M | -2.95M | -2.42M |
| EBITDA | -3.84M | -3.24M | -4.48M | -2.95M | -2.41M |
| EPS Basic | -19.51 | -18.18 | -16.40 | -11.73 | -10.51 |
| Normalized Basic EPS | -4.12 | -11.37 | -10.25 | -7.33 | -6.57 |
| EPS Diluted | -19.51 | -18.18 | -16.40 | -11.73 | -10.51 |
| Normalized Diluted EPS | -4.12 | -11.37 | -10.25 | -7.33 | -6.57 |
| Average Basic Shares Outstanding | 517.30K | 279.70K | 273.80K | 249.60K | 229.40K |
| Average Diluted Shares Outstanding | 517.30K | 279.70K | 273.80K | 249.60K | 229.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |